Houston, TX, United States of America

Sauradip Chaudhuri

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: The University of Texas System. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sauradip Chaudhuri. Retrieved from https://idiyas.com/inventor/sauradip-chaudhuri

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sauradip Chaudhuri: Innovator in Nanoparticle Formulations

Introduction

Sauradip Chaudhuri is a notable inventor based in Houston, TX (US). He has made significant contributions to the field of nanoparticle formulations, particularly through his innovative patent.

Latest Patents

Sauradip Chaudhuri holds a patent for "Formulations of cyclic macromolecule-based nanoparticles encapsulating small molecules." This patent describes a composition that includes a cross-linked network of cyclic macromolecules. The cyclic macromolecules are covalently cross-linked by various cross-linking agents, which may be functionalized with multiple functional groups. The composition can take the form of particles and is designed for administering active agents to subjects.

Career Highlights

Sauradip Chaudhuri is affiliated with the University of Texas System, where he continues to advance his research and development in the field of nanotechnology. His work has the potential to impact various applications in medicine and materials science.

Collaborations

Sauradip collaborates with Rachael Sirianni, contributing to the innovative research environment at the University of Texas System.

Conclusion

Sauradip Chaudhuri's work in nanoparticle formulations exemplifies the innovative spirit of modern science. His contributions are paving the way for advancements in drug delivery and therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…